Skip to content
Lower risk Drug recall · FDA · Published July 30, 2018

Major Pharmaceuticals Doxycycline Tablets Recall: Failed Dissolution Specifications

Major Pharmaceuticals is recalling 100 mg Doxycycline Hyclate Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for details.

🇺🇸 FDA recall #D-1026-2018DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmMAJOR PHARMACEUTICALS17177 N Laurel Park Dr · Livonia, MI 48152-2693
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling 100 mg Doxycycline Hyclate Tablets that failed dissolution tests. This could mean the medication doesn't work as intended, so affected users should check their prescription details. Read more at govinfonow.com/recall/39837-major-pharmaceuticals-doxycycline-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/39837-major-pharmaceuticals-doxycycline-tablets-recall-failed-dissolution-specifications · Updated October 6, 2026 · FDA enforcement record: FDA #D-1026-2018

Cite this page

“Major Pharmaceuticals Doxycycline Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39837-major-pharmaceuticals-doxycycline-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-1026-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1026-2018%22&limit=1).

The FDA announced on July 30, 2018, that Major Pharmaceuticals voluntarily recalled Doxycycline Hyclate Tablets due to failed dissolution specifications. The recall affects 3,161 cartons distributed nationwide.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only
  • Packaging: 30 tablets, 3 x 10 unit dose Cartons
  • Manufacturer: West-Ward Pharmaceuticals Corp.
  • NDC: 0904-0430-04
  • Lot code: 71545AA
  • Expiration date: 7/2019
  • Quantity: 3,161 Cartons

The hazard

The tablets failed dissolution specifications, according to the FDA. The recall classification is Class II.

Context

GovInfoNow's records show Major Pharmaceuticals has five other recalls on record since June 26, 2018. Other recent recalls of similar products include Ascend Minocycline Tablets Recall (June 1, 2026), Novartis Recalls Diovan 160mg Tablets Due to Failed Dissolution Specifications (August 4, 2026), and Inventia Healthcare Chlorthalidone Tablets Recall (June 5, 2026).

How to tell if you have this one

Check for the product name 'Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only, 30 tablets, 3 x 10 unit dose Cartons'. The manufacturer is West-Ward Pharmaceuticals Corp. and the NDC code is 0904-0430-04.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Prescription Details

    Review your prescription label for the product name and dosage to confirm if it matches the recalled items.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Jul 30, 201812. FDA classified it Class II: Aug 2, 201823. Published in FDA’s Enforcement Report: Aug 8, 201834. FDA terminated the recall: Dec 2, 2019420182019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Major Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1026-2018 (July 30, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1026-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA